Song et al., 2018 - Google Patents
Combining mGRASP and optogenetics enables high-resolution functional mapping of descending cortical projectionsSong et al., 2018
View HTML- Document ID
- 6436032332816478
- Author
- Song J
- Lucaci D
- Calangiu I
- Brown M
- Park J
- Kim J
- Brickley S
- Chadderton P
- Publication year
- Publication venue
- Cell reports
External Links
Snippet
We have applied optogenetics and mGRASP, a light microscopy technique that labels synaptic contacts, to map the number and strength of defined corticocollicular (CC) connections. Using mGRASP, we show that CC projections form small, medium, and large …
- 230000001054 cortical 0 title description 10
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kalmbach et al. | h-Channels contribute to divergent intrinsic membrane properties of supragranular pyramidal neurons in human versus mouse cerebral cortex | |
| Dudok et al. | Recruitment and inhibitory action of hippocampal axo-axonic cells during behavior | |
| Lazaro et al. | Reduced prefrontal synaptic connectivity and disturbed oscillatory population dynamics in the CNTNAP2 model of autism | |
| Cheng et al. | Vision-dependent specification of cell types and function in the developing cortex | |
| Tian et al. | Video-based pooled screening yields improved far-red genetically encoded voltage indicators | |
| Evans et al. | Functional dissection of basal ganglia inhibitory inputs onto substantia nigra dopaminergic neurons | |
| Livneh et al. | Odor processing by adult-born neurons | |
| Sinha et al. | Cellular and circuit mechanisms shaping the perceptual properties of the primate fovea | |
| Gentet et al. | Membrane potential dynamics of GABAergic neurons in the barrel cortex of behaving mice | |
| Vélez-Fort et al. | The stimulus selectivity and connectivity of layer six principal cells reveals cortical microcircuits underlying visual processing | |
| Little et al. | Subcellular synaptic connectivity of layer 2 pyramidal neurons in the medial prefrontal cortex | |
| Amadei et al. | Dynamic corticostriatal activity biases social bonding in monogamous female prairie voles | |
| Kerlin et al. | Broadly tuned response properties of diverse inhibitory neuron subtypes in mouse visual cortex | |
| Valero et al. | Determinants of different deep and superficial CA1 pyramidal cell dynamics during sharp-wave ripples | |
| Bloodgood et al. | The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition | |
| Milior et al. | Electrophysiological properties of CA1 pyramidal neurons along the longitudinal axis of the mouse hippocampus | |
| Vishwanathan et al. | Electron microscopic reconstruction of functionally identified cells in a neural integrator | |
| Kapoor et al. | Activation of raphe nuclei triggers rapid and distinct effects on parallel olfactory bulb output channels | |
| Kikuta et al. | Odorant response properties of individual neurons in an olfactory glomerular module | |
| Kiskinis et al. | All-optical electrophysiology for high-throughput functional characterization of a human iPSC-derived motor neuron model of ALS | |
| Piscopo et al. | Diverse visual features encoded in mouse lateral geniculate nucleus | |
| Suzuki et al. | Dendritic calcium spikes are clearly detectable at the cortical surface | |
| McBride et al. | Influence of claustrum on cortex varies by area, layer, and cell type | |
| Xu et al. | Primary visual cortex shows laminar‐specific and balanced circuit organization of excitatory and inhibitory synaptic connectivity | |
| Muñoz et al. | Channelrhodopsin-assisted patching: in vivo recording of genetically and morphologically identified neurons throughout the brain |